%0 Journal Article
%T Adjuvant therapy for intermediate risk factors in oral cancer: Can we reach a consensus?
%A Das S
%A Ghosh Laskar S
%A V Kane S
%A D'Cruz AK
%J Oral Oncol
%V 157
%N 0
%D 2024 Oct 30
%M 39083854
%F 5.972
%R 10.1016/j.oraloncology.2024.106972
%X Oral carcinoma is a common disease that poses challenges in treatment management, especially for advanced cases. Adjuvant therapies, such as radiation and chemoradiation therapy, are typically used for advanced oral cancer patients. However, there is uncertainty regarding the use of adjuvant therapy for early-stage patients with certain soft histological parameters. The UICC manual of clinical oncology suggests that adjuvant therapy for such parameters is desirable but not essential. These parameters include perineural invasion, lymphovascular invasion, single nodal positivity, and patterns of invasion, which complicate the decision-making process for including adjuvant therapy. This review aims to provide evidence-based literature for effectively managing this patient group and developing treatment protocols based on current evidence.